Health News (Reuters)

Lilly's cancer therapy Lartruvo fails study, shares drop

Eli Lilly and Co said on Friday its cancer treatment Lartruvo, approved on an accelerated basis in 2016, failed to improve patient survival in a long-term study and will no longer be prescribed, driving shares down nearly 3 percent.

FDA advisory panel split over Sanofi-Lexicon diabetes drug

Independent experts on an advisory panel to the U.S. Food and Drug Administration were divided over whether to recommend approval of a treatment for type 1 diabetes developed by Lexicon Pharmaceuticals Inc and France's Sanofi SA.

Doctors explain misconceptions about penicillin allergy

(Reuters Health) - Most patients who report having a penicillin allergy are not really allergic to this highly effective antibiotic, and they may be missing out on the best treatment for their condition as a result, according to a new patient resource published in JAMA.

Too little sleep tied to increased heart disease risk

(Reuters Health) - People who sleep less than six hours a night may be more likely to develop cardiovascular disease than those who sleep seven to eight hours, a Spanish study suggests.

Japan Tobacco ratchets up smokeless war with new products

Japan Tobacco Inc on Thursday unveiled two "heat-not-burn" products, as it races against market leader Philip Morris International Inc for a larger share of the vaping space with conventional cigarettes steadily falling out of favor.

Australia's aged care sector braces for powerful inquiry

A public inquiry into mistreatment of the elderly in Australia's A$20 billion ($14 billion) aged-care industry begins hearings on Friday, with investors expecting damaging testimony to be followed by tighter regulation and a possible sector shakeout.

Amgen's postmenopausal osteoporosis drug wins FDA panel backing

An advisory panel to the U.S. Food and Drug Administration on Wednesday recommended Amgen Inc's osteoporosis treatment for postmenopausal women at high risk for fracture, saying the benefits of the drug outweighed its risks.

3D-printed scaffold helps treat severed spinal cords in rats

(Reuters Health) - Patients with severed spinal cords once had no hope of regaining limb function. But a method that helps new nerve cells bridge the damage by growing through a scaffolding structure might one day change that, researchers say.

No quick fix for physician burnout, depression

NEW YORK (Reuters Health) - Close to 44 percent of U.S. physicians are burned out, and 15 percent are depressed and thinking about suicide, according to a survey conducted by Medscape.

U.S. attorney general nominee open to reconsidering healthcare position

President Donald Trump's pick to be the next U.S. Attorney General, William Barr, told a Senate panel on Tuesday he is willing to reconsider the Justice Department's current position of not defending the country's healthcare law, commonly called Obamacare, in court.